Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Furst

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Clinical and Experimental Rheumatology|March 20, 1999
The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritisD E Furst
Seminars in Arthritis and Rheumatism|October 1, 1993
Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic exampleD E Furst
Lupus|June 1, 1996
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseasesD E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Perspectives on the cyclooxygenase-2/ cyclooxygenase-1 hypothesisD E Furst
The Journal of Rheumatology|February 1, 1991
Defining the toxicity of disease modifying antirheumatic drugs in rheumatoid arthritisD E Furst
Drugs|January 1, 1990
Rational use of disease-modifying antirheumatic drugsD E Furst
Lancet (London, England)|August 30, 2000
Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?D E Furst
Current Opinion in Rheumatology|November 25, 2000
Rational therapy in the treatment of systemic sclerosisD E Furst
Current Rheumatology Reports|December 21, 2000
Oligo- and monoarticular inflammatory arthritis: a need and a hopeD E Furst
The Journal of Rheumatology. Supplement|April 1, 1992
Toxicity of antirheumatic medications in children with juvenile arthritisD E Furst
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Clinical and Experimental Rheumatology|March 20, 1999
The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritisD E Furst
Seminars in Arthritis and Rheumatism|October 1, 1993
Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic exampleD E Furst
Lupus|June 1, 1996
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseasesD E Furst
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Perspectives on the cyclooxygenase-2/ cyclooxygenase-1 hypothesisD E Furst
The Journal of Rheumatology|February 1, 1991
Defining the toxicity of disease modifying antirheumatic drugs in rheumatoid arthritisD E Furst
Drugs|January 1, 1990
Rational use of disease-modifying antirheumatic drugsD E Furst
Lancet (London, England)|August 30, 2000
Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?D E Furst
Current Opinion in Rheumatology|November 25, 2000
Rational therapy in the treatment of systemic sclerosisD E Furst
Current Rheumatology Reports|December 21, 2000
Oligo- and monoarticular inflammatory arthritis: a need and a hopeD E Furst
The Journal of Rheumatology. Supplement|April 1, 1992
Toxicity of antirheumatic medications in children with juvenile arthritisD E Furst
Pageof 26